PubMed:31249266 / 1504-1601 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/31249266","sourcedb":"PubMed","sourceid":"31249266","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/31249266","text":"Chlorzoxazone at 200-700 μM decreased cell viability, which was not reversed by pretreatment with","tracks":[{"project":"GoldHamster","denotations":[{"id":"T430","span":{"begin":0,"end":13},"obj":"2410"},{"id":"T427","span":{"begin":0,"end":13},"obj":"D002753"},{"id":"T428","span":{"begin":0,"end":13},"obj":"D002753"},{"id":"T429","span":{"begin":0,"end":13},"obj":"CHEBI:3655"}],"attributes":[{"subj":"T430","pred":"source","obj":"GoldHamster"},{"subj":"T427","pred":"source","obj":"GoldHamster"},{"subj":"T428","pred":"source","obj":"GoldHamster"},{"subj":"T429","pred":"source","obj":"GoldHamster"}]},{"project":"PubMed_ArguminSci","denotations":[{"id":"T13","span":{"begin":0,"end":97},"obj":"DRI_Approach"}],"attributes":[{"subj":"T13","pred":"source","obj":"PubMed_ArguminSci"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"GoldHamster","color":"#ec93c3","default":true},{"id":"PubMed_ArguminSci","color":"#93deec"}]}]}}